English Overview
Fatty liver is the accumulation of triglycerides in the liver and within liver cells (hepatocytes). It develops when the percentage of this fat deposition exceeds 5% of liver tissue weight. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease with a fast-growing prevalence in Saudi Arabia that parallels obesity and diabetes. NAFLD ranges from simple hepatic steatosis to non-alcoholic steatohepatitis (NASH). Most patients experience no symptoms that aggravate the progression of this disease. There is no approved treatment for NAFLD,however, it is important to control the risk factors, including high blood cholesterol, diabetes, and high blood pressure. Also, lifestyle modification and excellent control of co-morbid metabolic illness are urgently needed to prevent the disease progression.
IMPORTANT NOTE:
You can join and gain knowledge from this session for free. You also have the option to pay SR 75 to upgrade for some additional benefits. When you upgrade you will receive a certificate of achievement and 2 CME hours if you attend 70% of the session live.
This Activity for
- Resident / Fellow
- Physician
- Clinical Laboratory Sciences
What I will learn?
1. Describe the basic and advanced knowledge of theoretical and practical concepts regarding the fatty liver disease.
2. Recognize the importance of fatty liver in our community.
3. Identify several diagnostic techniques and procedures used to diagnose NAFLD.
4. Interpret the laboratory test results regarding NAFLD.
Main Them
Interactive online lecture for 2 hours
Speakers 1 Distinguished Speakers
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
The Silent Liver Disease in Saudi Arabia Cert Certificate
Accreditation |
Certificate | 86.25 SAR |
